{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:49:41Z","timestamp":1787165381690,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["G-332-165-1443"],"award-info":[{"award-number":["G-332-165-1443"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jsps.2023.101707","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T11:57:47Z","timestamp":1690113467000},"page":"101707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Suad","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.101707_b0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.25122\/jml-2021-0085","article-title":"Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals","volume":"15","author":"Acharya","year":"2022","journal-title":"J. Med. Life"},{"key":"10.1016\/j.jsps.2023.101707_b0010","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65: 369-376, 2007.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"10.1016\/j.jsps.2023.101707_b0015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J. Craniomaxillofac. Surg"},{"key":"10.1016\/j.jsps.2023.101707_b0020","first-page":"830","article-title":"Physicians' awareness of bisphosphonates-related osteonecrosis of the jaw","volume":"32","author":"Al-Mohaya","year":"2011","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.jsps.2023.101707_b0025","doi-asserted-by":"crossref","unstructured":"Ardawi M. S., Maimany Aa Fau - Bahksh Talal M., Bahksh Tm Fau - Nasrat Hasan A. N., Nasrat Ha Fau - Milaat Waleed A., Milaat Wa Fau - Al-Raddadi Raja M. and Al-Raddadi R. M.: Bone mineral density of the spine and femur in healthy Saudis. 2005.","DOI":"10.1007\/s00198-004-1639-9"},{"key":"10.1016\/j.jsps.2023.101707_b0030","first-page":"324","article-title":"Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays","volume":"60","author":"Brown","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.jsps.2023.101707_b0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2011.01.014","article-title":"Pharmacology of bisphosphonates","volume":"49","author":"Cremers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jsps.2023.101707_b0040","doi-asserted-by":"crossref","unstructured":"Dodson T. B.: The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. 2015.","DOI":"10.1016\/j.coms.2015.06.003"},{"key":"10.1016\/j.jsps.2023.101707_b0045","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s00520-015-2649-1","article-title":"Bisphosphonate-related osteonecrosis of the jaw: awareness and level of knowledge of Lebanese physicians","volume":"23","author":"El Osta","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jsps.2023.101707_b0050","doi-asserted-by":"crossref","unstructured":"Escobedo M., Garc\u00eda-Consuegra L., Junquera S., Olay S., Ascani G. and Junquera L.: Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain). 2018.","DOI":"10.1016\/j.jormas.2018.04.008"},{"key":"10.1016\/j.jsps.2023.101707_b0055","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsps.2023.101707_b0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsps.2023.101707_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"and International Task Force on Osteonecrosis of the Jaw: Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsps.2023.101707_b0070","doi-asserted-by":"crossref","unstructured":"LeBoff Ms Auid-Orcid, Greenspan S. L., Insogna K. L., Lewiecki E. M., Saag K. G., Singer A. J. and Siris E. S.: The clinician's guide to prevention and treatment of osteoporosis. 2022.","DOI":"10.1007\/s00198-021-05900-y"},{"key":"10.1016\/j.jsps.2023.101707_b0075","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsps.2023.101707_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"S., and Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure Investigators: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2023.101707_b0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2023.101707_b0090","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1007\/s00520-020-05374-4","article-title":"Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals","volume":"28","author":"Miranda-Silva","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jsps.2023.101707_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.jsps.2023.101707_b0100","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2023.101707_b0105","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2023.101707_b0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jsps.2023.101707_b0115","doi-asserted-by":"crossref","unstructured":"Yamori M., Tamura M., Mikami M., Mori T., Noi M., Machida Y., Koshinuma S. and Yamamoto G.: Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients. Int Dent J2021.","DOI":"10.1016\/j.identj.2020.12.005"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:28:28Z","timestamp":1736166508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1319016423002025"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101707","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101707"}}